News
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS.REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks ...
Recursion Vets Unveil Startup Noetik, Using AI to Unlock Tumor Biology By revealing how tumors interact with immune cells, Noetik aims to identify new targets for new cancer drugs.
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS.REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback